SANA
Sana Biotechnology, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -7.4% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 49.50K | $139,113 | n/a | n/a |
| Q2 2026 | 85 | +4 | 119.01M | $415.23M | +9 | −5 |
| Q1 2026 | 84 | -3 | 118.01M | $339.95M | +3 | −6 |
| Q4 2025 | 87 | +2 | 116.35M | $473.54M | +2 | n/a |
| Q3 2025 | 15 | -2 | 97.26M | $345.27M | n/a | −2 |
| Q2 2025 | 14 | 0 | 77.71M | $212.16M | +2 | −2 |
| Q1 2025 | 11 | -1 | 31.65M | $53.17M | +1 | −2 |
| Q4 2024 | 12 | -1 | 32.20M | $52.48M | +1 | −2 |
| Q3 2024 | 12 | +2 | 22.88M | $95.19M | +2 | n/a |
| Q2 2024 | 10 | n/a | 23.15M | $126.39M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 33.83M | n/a | $92.36M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 2 | BlackRock ✦ (passief) | 10.86M | n/a | $29.64M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 3 | Baillie Gifford ✦ | 10.06M | -1.2% | $27.48M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 4 | The Vanguard Group ✦ (passief) | 7.61M | n/a | $20.78M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 5 | Geode Capital Management ✦ (passief) | 3.28M | +0.1% | $8.96M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 2.96M | -13.2% | $8.07M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passief) | 2.86M | -47.9% | $7.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 2.56M | -3.6% | $6.98M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | AQR Capital Management ✦ | 1.36M | +136.7% | $3.70M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 10 | Millennium Management ✦ | 797.58K | +236.3% | $2.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 702.00K | Nieuw | $1.92M | 0.0% | New | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 611.79K | +469.2% | $1.67M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 203.71K | Nieuw | $556,134 | 0.0% | New | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 20.79K | -60.0% | $56,762 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Adage Capital Partners | $1.92M | 0.0% |
| Renaissance Technologies | $556,134 | 0.0% |
Verlaten
| Capital World Investors | $9.15M | was 0.0% |
| Marshall Wace | $354,861 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 199 houders, 163.30M aandelen, $468.43M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.